BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Business

  Kythera Biopharmaceuticals Appoints F. Michael Ball to Board of Directors

  September 20, 2013

   · 

  1 min read
• Teva Pharmaceutical Industries Limited Announces Exclusive Launch of Generic NIASPAN® in the United States

  September 20, 2013

   · 

  1 min read
• Genetown

  OvaScience Reports Inducement Option Grant Under NASDAQ Rule 5635(c)(4)

  September 20, 2013

   · 

  1 min read
• Drug Development

  Eleven Biotherapeutics Presents Positive Clinical Data on EBI-005, a Targeted Protein Therapeutic for Highly Selective Topical Blockade of IL-1 in Patients With Dry Eye Disease

  September 20, 2013

   · 

  1 min read
• Pharm Country

  MD Stem Cells Begins the Largest Stem Cell Eye Treatment Study to Date

  September 20, 2013

   · 

  2 min read
• Policy

  Sapheon, Inc. Submits First Module of PMA Application for VenaSeal® Sapheon Closure System

  September 20, 2013

   · 

  1 min read
• Deals

  BIND Therapeutics Scrounges Up $70.5 Million in IPO

  September 20, 2013

   · 

  2 min read
• Drug Development

  GlaxoSmithKline, ProSensa Holding N.V.'s Muscular Dystrophy Drug Fails in Phase 3 Trial; ProSensa Stock Plunges -70.25% at Market Close on September 20, 2013

  September 20, 2013

   · 

  8 min read
• Policy

  Sanofi Settles Lawsuit Over Obesity Drug for $40 Million

  September 20, 2013

   · 

  1 min read
• Business

  Intrexon Announces Second Quarter Financial Results

  September 20, 2013

   · 

  1 min read